Intravascular ImagingEdit

Intravascular imaging refers to catheter-based technologies that visualize the interior of coronary vessels during interventional procedures. By providing direct, in vivo views of lumen dimensions, plaque morphology, and stent apposition, these modalities aim to complement traditional angiography and improve procedural accuracy, safety, and long-term outcomes. The field encompasses several distinct technologies, each with its own strengths and limitations, and it has become a standard part of many complex percutaneous coronary interventions (Percutaneous coronary intervention), as well as in certain diagnostic settings.

Across the interventional cardiology community, there is ongoing discussion about when intravascular imaging adds value for patient care and how to balance costs, training, and workflow. Proponents point to improved lesion characterization, better stent sizing and expansion, and the potential to reduce repeat procedures; critics emphasize the additional time, contrast exposure, and equipment costs, arguing that benefits may be greatest in selected cases rather than routine use. This debate is shaped by lesion complexity, patient risk, and the evolving evidence base in randomized trials and meta-analyses.

History and background

Intravascular imaging has evolved from simple angiography, which provides a two-dimensional silhouette of the vessel, to high-resolution, three-dimensional assessments of plaque and devices. Intravascular ultrasound (Intravascular ultrasound) emerged first as a real-time ultrasound method that could visualize vessel walls and measure lumen and vessel size. Over time, optical coherence tomography (Optical coherence tomography) offered higher spatial resolution and tissue characterization, albeit with shallow penetration and a need for blood clearance during imaging. More recently, spectroscopic approaches such as near-infrared spectroscopy (Near-infrared spectroscopy) have enabled assessment of lipid-rich plaque components. These modalities can be used individually or in combination to guide decision-making during PCI and to refine postoperative assessment.

Modalities

Intravascular ultrasound (IVUS)

IVUS uses high-frequency ultrasound emitted from a catheter-based transducer to generate cross-sectional images of the vessel. It provides good mural visualization, accurate lumen and reference-vessel sizing, and the ability to assess plaque burden and calcification. IVUS is less sensitive to motion and does not require blood clearance, making it robust in a range of settings. It remains particularly useful for evaluating left main disease, complex bifurcations, and ambiguous angiographic findings.

Optical coherence tomography (OCT)

OCT uses near-infrared light to produce very high-resolution cross-sectional images, enabling fine discrimination of tissue structure, cap morphology, microdissections, and stent apposition. Its superior resolution makes it especially helpful for post-PCI optimization, including assessment of stent malapposition, edge dissections, and minor residual thrombus. OCT requires thorough flushing of blood from the imaging field or saline exchange, which can add procedural steps and time.

Near-infrared spectroscopy (NIRS)

NIRS detects lipid-rich plaque components by analyzing spectral signals from the vessel wall. When used with other modalities, NIRS can help identify vulnerable or complex plaque features that may influence treatment strategy, particularly in planning preventive strategies and selecting treatment approaches for high-risk lesions.

Multimodality imaging

In some procedures, operators combine modalities (for example, IVUS with NIRS, or OCT with IVUS) to exploit complementary information—IVUS for overall sizing and vessel remodeling, OCT for microstructural detail, and NIRS for plaque composition. Such integrated approaches can enhance decision-making in challenging anatomy or when precise optimization is essential.

Clinical applications

  • Pre-procedural assessment: Characterizing lesion length, reference vessel size, and plaque burden helps in selecting stent size and length, and in planning strategies for complex lesions or calcified plaques.

  • Stent sizing and deployment: Accurate lumen and reference-vessel measurements improve stent sizing and help ensure optimal expansion, which is associated with better long-term patency and fewer complications.

  • Post-PCI optimization: Immediate evaluation for stent malapposition, underexpansion, edge dissections, or residual stenosis allows correction before completing the procedure, potentially reducing adverse events.

  • Left main and complex disease: Intravascular imaging guidance has been emphasized in left main and bifurcation lesions where angiography alone may underestimate complexity, and where imaging can guide more precise intervention.

  • Plaque characterization and risk assessment: Beyond immediate procedural goals, imaging findings contribute to understanding plaque morphology and planning future management, though the impact on long-term outcomes varies by patient and lesion type.

Evidence and controversies

  • Outcomes with imaging-guided PCI: A substantial body of randomized data and meta-analyses suggests benefits of intravascular imaging over angiography-guided PCI in certain populations, particularly in complex lesions, left main disease, and bifurcations. Reported advantages include higher rates of optimal stent deployment and, in some studies, reduced target-vessel revascularization and major adverse cardiac events over follow-up.

  • Modality-specific evidence: IVUS has long been associated with improved procedural quality and outcomes in selected cases, while OCT excels in post-PCI assessment and in detecting subtle issues that other modalities might miss. The choice of modality often reflects the clinical question, operator expertise, and device availability. Combining modalities can enhance diagnostic confidence but adds complexity and cost.

  • Routine vs selective use: Many centers reserve intravascular imaging for complex or high-risk PCI, left main disease, ambiguous angiographic findings, or situations where precise stent optimization is critical. Proponents argue that selective use maximizes patient benefit while controlling costs; opponents contend that broader adoption in appropriate cases could improve overall outcomes, though data on universal screening are mixed.

  • Cost, training, and workflow: The economic argument centers on device cost, longer procedure times, and required operator training. When imaging reduces complications or reinterventions in high-risk cases, cost-effectiveness improves; in straightforward lesions, the incremental value may be modest. Institutions weigh these factors when integrating imaging into practice.

  • Guidelines and expert consensus: Professional societies generally endorse selective use of intravascular imaging in specific scenarios, such as complex lesions, left main disease, or when angiographic results are suboptimal. Recommendations emphasize how imaging can inform sizing, deployment, and optimization, rather than mandating its routine use in all PCI cases.

Safety, limitations, and practical considerations

  • Procedural considerations: Intravascular imaging adds time and requires additional catheter exchanges and contrast administration, potentially increasing exposure to radiation and contrast in susceptible patients. Efficient workflows and operator experience influence the practical burden.

  • Imaging limitations: Each modality has intrinsic limitations—IVUS offers reliable wall visualization but lower resolution for microscopic features; OCT provides high-resolution surface detail but requires meticulous blood clearance and may not penetrate deeply into very calcified plaques; NIRS adds compositional information but lacks full guidance on mechanical optimization without a complementary modality.

  • Patient selection and risk stratification: Given finite resources, imaging is most impactful when tailored to patient risk, lesion complexity, and procedural goals. Careful assessment of potential benefits versus procedural burden helps determine the appropriate use.

Future directions

  • Artificial intelligence and automated analysis: Advances in AI are aiding real-time interpretation, automatic detection of malapposition or underexpansion, and standardized reporting, which can shorten procedure times and reduce variability.

  • Expanded indications and technology integration: Ongoing research explores broader indications for imaging-guided PCI, refinements in catheter design, and the integration of imaging data with functional measurements (such as physiologic indexing) to guide therapy more precisely.

  • Patient-centered outcomes and cost-effectiveness: As data accumulate, the focus is shifting toward identifying subgroups most likely to benefit from imaging-guided strategies and translating imaging findings into tangible improvements in quality of life and long-term costs.

See also